Citation Impact
Citing Papers
Postexposure Effects of Vaccines on Infectious Diseases
2019
Small RNAs in Bacteria and Archaea
2015
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay
1991 StandoutNobel
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDS
1989 StandoutNobel
An RNA-seq based comparative approach reveals the transcriptome-wide interplay between 3′-to-5′ exoRNases and RNase Y
2020 StandoutNobel
RNA-based recognition and targeting: sowing the seeds of specificity
2017 StandoutNobel
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
1989 StandoutNobel
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors
1996 Standout
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
1989 StandoutNobel
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1989 StandoutNobel
A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan
1989 StandoutNobel
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.
1999
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
Then and now: The progress in hepatitis B treatment over the past 20 years
2014
An Assessment of Clinically Useful Measures of the Consequences of Treatment
1988
Assembly of Hepadnaviral Virions and Subviral Particles
1991
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
1995 StandoutNature
Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.
1991
The global impact of vaccination against hepatitis B: A historical overview
2008
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma
1990 StandoutNobel
Decay characteristics of HIV-1-infected compartments during combination therapy
1997 StandoutNature
Hepatocellular Carcinoma
2011 Standout
Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants
2001 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Hepatitis C antibody and chronic liver disease in haemophilia
1990 StandoutNobel
Hepatitis B Vaccine in Medical Staff of Hemodialysis Units
1982
In vivo 3′-to-5′ exoribonuclease targetomes of Streptococcus pyogenes
2018 StandoutNobel
Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C.
1993 StandoutNobel
Analysis of Processing and Polyadenylation Signals of the Hepatitis B Virus Surface Antigen Gene by Using Simian Virus 40-Hepatitis B Virus Chimeric Plasmids
1983
When Ribonucleases Come into Play in Pathogens: A Survey of Gram-Positive Bacteria
2012
Antibodies to the Core Protein of Lymphadenopathy-Associated Virus (LAV) in Patients with AIDS
1984 StandoutScienceNobel
The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay.
1995 StandoutNobel
A Larger Spectrum of Severe HIV-1—Related Disease in Intravenous Drug Users in New York City
1988 Science
Hepatitis B Vaccine in Patients Receiving Hemodialysis
1984
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
1989 StandoutScienceNobel
Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src
1983 StandoutNobel
The Prevention of Hepatitis B with Vaccine
1982
RNA Degradation inStaphylococcus aureus: Diversity of Ribonucleases and Their Impact
2015
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
1983
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
2021 Standout
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Efficient isolation of genes by using antibody probes.
1983 Standout
Importance of Heterosexual Activity in the Transmission of Hepatitis B and Non-A, Non-B Hepatitis
1989
Viral dynamics in human immunodeficiency virus type 1 infection
1995 StandoutNature
Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons
1996
Analysis of processing and polyadenylation signals of the hepatitis B virus surface antigen gene by using simian virus 40-hepatitis B virus chimeric plasmids.
1983
Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells.
1983
Synthesis of hepatitis B surface and core antigens in E. coli
1981 Nature
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
1991 Standout
Expression of human immunoglobulin E ε chain cDNA inE.coli
1983 StandoutNobel
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.
1990 StandoutNobel
Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene
1986 StandoutNobel
Actual Causes of Death in the United States
1993 Standout
RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: I, MEDICAL STAFF
1981
Early events in hepatitis C virus infection of chimpanzees.
1990 StandoutNobel
Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.
1995 StandoutNobel
Genetic organization and diversity of the hepatitis C virus.
1991 Standout
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 StandoutScienceNobel
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1
1994 StandoutNobel
Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
1993
Works of John M. Morrison being referenced
Small Molecule Inhibitors of Staphylococcus aureus RnpA Alter Cellular mRNA Turnover, Exhibit Antimicrobial Activity, and Attenuate Pathogenesis
2011
The staphylococcal accessory regulator, SarA, is an RNA-binding protein that modulates the mRNA turnover properties of late-exponential and stationary phase Staphylococcus aureus cells
2012
Hepatitis B Vaccine
1980